Epitomee Medical Ltd (TLV:EPIT)
Israel · Delayed Price · Currency is ILS · Price in ILA 414.70
-43.70 (-9.53%)
Jul 3, 2026, 1:44 PM IDT
Epitomee Medical Market Cap
Epitomee Medical has a market cap or net worth of 125.07 million as of July 2, 2026. Its market cap has decreased by -51.91% in one year.
Market Cap
125.07M
Enterprise Value
99.30M
Revenue
679.04K
Ranking
n/a
PE Ratio
n/a
Stock Price
414.70
Market Cap Chart
Since December 15, 2021, Epitomee Medical's market cap has decreased from 1.21B to 125.07M, a decrease of -89.63%. That is a compound annual growth rate of -39.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2026 | 125.07M | -31.36% |
| Dec 31, 2025 | 182.22M | -32.71% |
| Dec 31, 2024 | 270.81M | 149.63% |
| Dec 31, 2023 | 108.48M | -67.89% |
| Dec 29, 2022 | 337.85M | -63.70% |
| Dec 30, 2021 | 930.82M | -22.80% |
| Dec 15, 2021 | 1.21B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 116.13B |
| Danel (Adir Yeoshua) | 2.74B |
| Amal Holdings A.D. | 2.37B |
| BrainsWay | 1.84B |
| Geffen Residence & Renewal | 304.01M |
| InterCure | 185.32M |
| Golden House | 163.08M |
| Rekah Pharmaceutical Industry | 124.88M |